Literature DB >> 24573490

Kelp use in patients with thyroid cancer.

Jennifer E Rosen1, Paula Gardiner, Robert B Saper, Elizabeth N Pearce, Kallista Hammer, Rebecca L Gupta-Lawrence, Stephanie L Lee.   

Abstract

To report on the incidence and use of kelp among patients with thyroid cancer. Data were collected using a web-based online anonymous survey under Institutional Review Board approval from Boston University. This report is based on 27 responses from subjects with thyroid cancer who use kelp. Demographic factors and complementary and alternative use were included. Respondents were primarily over age 40, white, female and have at least a high school education. The top five modalities were multivitamins, special diets, herbal supplements, prayer for health reasons and herbal tea. Only one patient reported perceiving a particular modality had a negative effect on treatment. Complementary and alternative medicine (CAM) was more often perceived as being used to aid their thyroid cancer treatment than to help with symptoms. On average, respondents who use kelp also use at least 11 additional CAM modalities. Only 1/2 of respondents who use kelp reported telling their physicians about their CAM use, and nearly 1/3 of respondents reported their CAM use was neither known, prescribed nor asked about by their physicians. In comparison to both national surveys of the general US population and patients with thyroid cancer, kelp users with thyroid cancer use at least twice the number of additional CAM therapies and report their use far less often. Physicians who treat patients with thyroid cancer should be aware of these data to further assist in their assessment and care.

Entities:  

Mesh:

Year:  2014        PMID: 24573490     DOI: 10.1007/s12020-013-0048-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  Excess iodine from an unexpected source.

Authors:  Seth M Arum; Xuemei He; Lewis E Braverman
Journal:  N Engl J Med       Date:  2009-01-22       Impact factor: 91.245

Review 2.  Iodine and differentiated thyroid cancer: pathogenetic and therapeutic implications.

Authors:  Peter Smyth; George Cloughley; Cathy Clarke; Derek Smith; Emma Burbridge
Journal:  Hormones (Athens)       Date:  2009 Jul-Sep       Impact factor: 2.885

3.  Transient hyperthyroidism in a patient taking dietary supplements containing kelp.

Authors:  B C Eliason
Journal:  J Am Board Fam Pract       Date:  1998 Nov-Dec

Review 4.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

5.  Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study.

Authors:  Takehiro Michikawa; Manami Inoue; Taichi Shimazu; Norie Sawada; Motoki Iwasaki; Shizuka Sasazuki; Taiki Yamaji; Shoichiro Tsugane
Journal:  Eur J Cancer Prev       Date:  2012-05       Impact factor: 2.497

6.  Variability of iodine content in common commercially available edible seaweeds.

Authors:  Jane Teas; Sam Pino; Alan Critchley; Lewis E Braverman
Journal:  Thyroid       Date:  2004-10       Impact factor: 6.568

7.  The use of complementary and alternative medicine therapies by patients with advanced cancer and pain in a hospice setting: a multicentered, descriptive study.

Authors:  Lisa W Corbin; B Karen Mellis; Brenda L Beaty; Jean S Kutner
Journal:  J Palliat Med       Date:  2009-01       Impact factor: 2.947

8.  Teaching complementary medicine at an academic oncology department.

Authors:  Eran Ben-Arye; Moshe Frenkel; Gil Bar-Sela; Ruth Stashefsky Margalit; Doron Hermoni; Abraham Kuten
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

9.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

10.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.

Authors:  Katsuya Tasaki; Gertraud Maskarinec; Dianne M Shumay; Yvonne Tatsumura; Hisako Kakai
Journal:  Psychooncology       Date:  2002 May-Jun       Impact factor: 3.894

View more
  1 in total

1.  Zonarol, a sesquiterpene from the brown algae Dictyopteris undulata, provides neuroprotection by activating the Nrf2/ARE pathway.

Authors:  Hiroya Shimizu; Tomoyuki Koyama; Sohsuke Yamada; Stuart A Lipton; Takumi Satoh
Journal:  Biochem Biophys Res Commun       Date:  2015-01-23       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.